More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana Inc. Applauds Victories for Veterans, Lone Star State

Medical Marijuana Inc. Applauds Victories for Veterans, Lone Star State

by adminAdrianRamirez | May 22, 2015 | Company News, Dixie Botanicals, HempMeds, Press Releases

Historic Vote by Senate Appropriations Committee Provides Veterans Access to Medical Cannabis in Legalized States; Texas Also Approves Limited Medical Marijuana Bill SAN DIEGO, May 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading...
AXIM Biotech’s New Website Commissioned to Award Winning Artist Andre Weinfeld

AXIM Biotech’s New Website Commissioned to Award Winning Artist Andre Weinfeld

by adminAdrianRamirez | May 19, 2015 | Axim Biotechnologies, Company News, Press Releases

Industrial Hemp Biotech’s Mission Conveyed Through the Eyes of Renowned Director and Artist NEW YORK (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (AXIM), a leader in industrial hemp biosciences, is proud to announce the launch of its new website...
Brazilian Government Approves Medical Marijuana Inc.’s New Partner HempMeds Brasil™ and Their Products as a Prescription Medication for Import

Brazilian Government Approves Medical Marijuana Inc.’s New Partner HempMeds Brasil™ and Their Products as a Prescription Medication for Import

by adminAdrianRamirez | May 18, 2015 | Company News, Press Releases

Historic Milestone: U.S. Company’s Cannabis Product Approved for Import in Brazil; the Brazilian Government Has Subsidized the Product for Many and HempMeds Brasil™ Has Received Its First Insurance Reimbursements San Diego, CA – May 18, 2015 – Cannabis has been...
AXIM Biotech Secures Exclusive License Agreement to Patented Cannabidiol (CBD) Gum

AXIM Biotech Secures Exclusive License Agreement to Patented Cannabidiol (CBD) Gum

by adminAdrianRamirez | May 14, 2015 | Axim Biotechnologies, Company News, Press Releases

CBD Hemp Oil Chewing Gum Provides Discrete Option for Hemp Consumers Worldwide NEW YORK, May 14, 2015 (GLOBE NEWSWIRE) — Industrial hemp biosciences industry leader, AXIM Biotechnologies, Inc. (OTC:AXIM), is proud to announce that the Company has successfully...
Medical Marijuana Inc. Portfolio Company Kannaway Awarded Start-Up of the Year

Medical Marijuana Inc. Portfolio Company Kannaway Awarded Start-Up of the Year

by adminAdrianRamirez | May 8, 2015 | Company News, Kannakick, Kannaway, Press Releases

Academy of Multi-Level Marketing (TAMM) Recognizes Kannaway as Industry-Leading Start-Up Company in 2014 SAN DIEGO, May 8, 2015 –  Kannaway, LLC, the first hemp lifestyle network marketing company to offer natural cannabidiol (CBD) hemp botanical products, is proud to...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.